Avanos Medical, Inc. (NYSE: AVNS) AI-Powered Stock Analysis
See how Avanos Medical, Inc. scores across key metrics like financial growth, valuation, and market position on the NYSE, using AI-driven evaluation.
AVNS●NYSE
HealthcareMedical - Devices
$24.99
$0.010(0.04%)
U.S. Market opens in 3h 5m
Avanos Medical, Inc. (NYSE: AVNS) AI-Powered Stock Analysis
See how Avanos Medical, Inc. scores across key metrics like financial growth, valuation, and market position on the NYSE, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerAvanos Medical, Inc. (NYSE: AVNS) Stock Overall Grade
Avanos Medical, Inc.'s grade for its NYSE listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Avanos Medical, Inc.'s overall NYSE stock rating.
Forecast
B+Score
76/100Financial Growth
CScore
45/100Fundamental Growth
CScore
41/100Key Ratios
C+Score
57/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
C+Score
50/100Avanos Medical, Inc. (NYSE: AVNS) AI-Powered Stock Analysis
On the NYSE, AVNS demonstrates Good performance with an overall Forecast Score of 76/100 (B+), reflecting high confidence in its potential. Financial Growth (45/100, C) and Fundamental Growth (41/100, C) highlight its stability, while Key Ratios (57/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), the NYSE-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(NYSE: AVNS) Component Analysis Explained
Understand the key factors behind each Avanos Medical, Inc. (NYSE: AVNS) stock grade, including financials, comparisons, and forecasts.